Lipoplexes with alkylphospholipid as new helper lipid for efficient in vitro and in vivo gene transfer in tumor therapy

Cancer Gene Therapy

Volumn 10, Issue 4, 2003, Pages 302-311

  Zeisig, Reinhard ^a   Ress, Angelika ^a,b   Fichtner, Iduna ^a   Walther, Wolfgang ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alkylphospholipids; Cationic liposomes; Gene transfer; Helper lipid; Lipoplex

Indexed keywords

ALKYLPHOSPHOLIPID; CHOLESTEROL; CYTOSINE DEAMINASE; DIMETHYLDIOCTADECYLAMINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; FLUCYTOSINE; LIPID; LIPOFECTIN; LIPOSOME; PHOSPHOLIPID DERIVATIVE; PRODRUG; TETRADECYLPHOSPHOCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL MEMBRANE; COLON CARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; GENE DELIVERY SYSTEM; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; REPORTER GENE; SUICIDE GENE; SUICIDE GENE THERAPY;

ANIMALS; BETA-GALACTOSIDASE; CELL LINE, TUMOR; CHOLESTEROL; COLORECTAL NEOPLASMS; CYTOSINE DEAMINASE; GENETIC VECTORS; HCT116 CELLS; HUMANS; LIPOSOMES; MICE; MICE, INBRED BALB C; NEOPLASMS; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPIDS; PLASMIDS; QUATERNARY AMMONIUM COMPOUNDS; TRANSFECTION; TRANSFERASES;

ANIMALIA;

EID: 0037384279     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700572     Document Type: Article

References (44)

1. Lasic DD. Recent developments in medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery. J Controlled Release. 1997;48:203-222.
2. Templeton NS, Lasic DD. New directions in liposome gene delivery. Mol Biotechnol. 1999;11:175-180.
3. Zhao DD, Watarai S, Lee JT, et al. Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids. Acta Med Okayama. 1997;51:149-154.
4. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 1995;2:710-722.
5. Yang K, Clifton GL, Hayes RL. Gene therapy for central nervous system injury: the use of cationic liposomes: an invited review. J Neurotrauma. 1997;14:281-297.
6. Lee RJ, Huang L. Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst. 1997;14:173-206.
7. Maurer N, Mori A, Palmer L, et al. Lipid-based systems for the intracellular delivery of genetic drugs. Mol Membr Biol. 1999;16:129-140.
8. Templeton NS, Lasic DD, Frederik PM, et al. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol. 1997;15:647-652.
9. Zhdanov RI, Kutsenko NG, Fedchenko VI. Nonviral methods of gene transfer in gene therapy. Vopr Med Khim. 1997;43:3-12.
10. Banerjee R, Das PK, Srilakshmi GV, et al. Novel series of non-glycerol-based cationic transfection lipids for use in liposomal gene delivery. J Med Chem. 1999;42:4292-4299.
11. Felgner PL, Barenholz Y, Behr JP, et al. Nomenclature for synthetic gene delivery systems [editorial]. Hum Gene Ther. 1997;8:511-512.
12. Flechsler I, Surovoy A, Charisse K, et al. Comparison of antisense vectors and antisense oligonucleotides delivered by means of the new cationic lipids unifectin and maxifectin. Adv Exp Med Biol. 1998;451:469-472.
13. Szala S, Missol E, Sochanik A, et al. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors. Gene Ther. 1996;3:1026-1031.
14. Li S, Rizzo MA, Bhattacharya S, et al. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. 1998;5:930-937.
15. Sternberg B, Hong K, Zheng W, et al. Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. Biochim Biophys Acta. 1998;1375:23-35.
16. Ergezinger K, Vehmeyer K, Unger C. Stimulation of human hematopoietic progenitor cells by the alkylphosphocholines hexadecylphosphocholine and hexadecyl-N,N,N-trimethylhexanolamine. Anticancer Res. 1999;19:3213-3219.
17. Heesbeen EC, Verdonck LF, Hermans SW, et al. Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cells. FEBS Lett. 1991;290:231-234.
18. Rakhmanova VA, MCintosh TJ, MacDonald RC. Effects of dioleoylphosphatidyl-ethanolamine on the activvity and structure of o-alkyl phosphatidylcholine-DNA transfection complexes. Chem Pharm Bull Tokyo. 2000;5:51-65.
19. Zeisig R, Eue I, Kosch M, et al. Preparation and properties of sterically stabilized hexadecylphosphocholine (miltefosine)-liposomes and influence of this modification on macrophage activation. Biochim Biophys Acta. 1996;1283:177-184.
20. Brattain MG, Fine WD, Khaled FM, et al. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 1981;41:1751-1756.
21. Iwahashi T, Okochi E, Ono K, et al. Establishment of multidrug resistant human colorectal carcinoma HCT-15 cell lines and their properties. Anticancer Res. 1991;11:1309-1312.
22. Lim K, Chae CB. A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase. Biotechniques. 1989;7:576-579.
23. Walther W, Stein U, Fichtner I, et al. Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Ther. 2001;8:173-180.
24. Mayhew E, Ahmad I, Bhatia S, et al. Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent. Biochim Biophys Acta. 1997;1329:139-148.
25. Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer. 1987;56:279-285.
26. Plowman J, Dykes DJ, Hollingshead M, et al. Human tumor xenograft models in NCI drug development. In: Teicher B, ed. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval. Totowa, HJ: Humana Press Inc; 1997:101-125.
27. Hilgard P, Stekar J, Klenner T, et al. Heterocyclic alkylphospholipids with an improved therapeutic range. Adv Exp Med Biol. 1996;416:157-164.
28. Kudo I, Nojima S, Chang HW, et al. Antitumor activity of synthetic alkylphospholipids with or without PAF activity. Lipids 1987;22:862-867.
29. Wang YZ, Liu XY, Wu LJ, et al. Antiproliferation effects of hexadecylphosphocholine on solid tumor and leukaemia selectively in vitro. Drugs Exp Clin Res. 1997;23:97-102.
30. Zeisig R, Arndt D, Brachwitz H. Ether lipids - synthesis and application in tumor therapy. Pharmazie. 1990;45:809-818.
31. Zeisig R, Jungmann S, Arndt D, et al. Antineoplastic activity in vitro of free and liposomal alkylphosphocholines. Anticancer Drugs. 1993;4:57-64.
32. Munder PG, Westphal O. Antitumoral and other biomedical activities of synthetic ether lysophospholipids. Chem Immunol. 1990;49:206-235.
33. Birchall JC, Kellaway IW, Mills SN. Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes. Int J Pharmacol. 1999;183:195-207.
34. MacDonald RC, Rakhmanova VA, Choi KL, et al. O-ethylphosphatidylcholine: a metabolizable cationic phospholipid which is a serum-compatible DNA transfection agent. J Pharm Sci. 1999;88:896-904.
35. Mok KW, Cullis PR. Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys J. 1997;73:2534-2545.
36. Ouatas T, Le Mevel S, Demeneix BA, et al. T3-dependent physiological regulation of transcription in the Xenopus tadpole brain studied by polyethylenimine based in vivo gene transfer. Int J Dev Biol. 1998;42:1159-1164.
37. Peters MT, Brigham KL, King GA, et al. Optimization of cationic liposome-mediated gene transfer to human bronchial epithelial cells expressing wild-type or abnormal cystic fibrosis transmembrane conductance regulator (CFTR). Exp Lung Res. 1999;25:183-197.
38. Stegmann T, Legendre JY. Gene transfer mediated by cationic lipids: lack of a correlation between lipid mixing and transfection. Biochim Biophys Acta. 1997;1325:71-79.
39. Pollard H, Remy JS, Loussouarn G, et al. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem. 1998;273:7507-7511.
40. Fasbender AJ, Zabner J, Welsh MJ. Optimization of cationic lipid-mediated gene transfer to airway epithelia. Am J Physiol. 1995;269:L45-L51.
41. Simoes S, Slepushkin V, Pretzer E, et al. Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides. J Leukoc Biol. 1999;65:270-279.
42. Wong FM, Reimer DL, Bally MB. Cationic lipid binding to DNA: characterization of complex formation. Biochemistry. 1996;35:5756-5763.
43. Hara T, Kuwasawa H, Aramaki Y, et al. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes. Biochim Biophys Acta. 1996;1278:51-58.
44. Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta. 1995;1235:289-295.